Stock Events

Stock Events

Claritas Pharmaceuticals 

$0.000100
2
+$0.00+0%Thursday 20:00

Statistics

Day High
0.0001
Day Low
0.0001
52W High
0.0001
52W Low
0.0001
Volume
250
Avg. Volume
0
Mkt Cap
0
P/E Ratio
0
Dividend Yield
-
Dividend
-

Upcoming

Earnings

Nov 30Expected
Q3 2024
Q1 2025
Q2 2025
Q3 2025
Q4 2025
Q1 2026
Next
999
333
-333
-999
Expected EPS
N/A
Actual EPS
N/A

Financials

-Profit Margin
Profitable
2015
2016
2017
2018
2019
2020
0Revenue
4.21MNet Income

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Pfizer
PFE
Mkt Cap173.95B
Pfizer is a major player in the pharmaceutical industry, developing drugs that can compete directly with Claritas Pharmaceuticals' offerings.
Merck
MRK
Mkt Cap368.89B
Merck produces a wide range of pharmaceutical products that could compete in the same therapeutic areas as Claritas Pharmaceuticals.
Johnson & Johnson
JNJ
Mkt Cap657.68B
Johnson & Johnson, through its pharmaceutical division, develops medications that may overlap with the treatments offered by Claritas Pharmaceuticals.
GSK
GSK
Mkt Cap99.19B
GlaxoSmithKline focuses on a broad portfolio of drugs, potentially competing in the same niche as Claritas Pharmaceuticals.
Novartis
NVS
Mkt Cap303.67B
Novartis is known for its innovative medicines and could have competing products in the same categories as Claritas Pharmaceuticals.
Abbvie
ABBV
Mkt Cap521.11B
AbbVie operates in similar therapeutic areas and could have drugs that compete with those of Claritas Pharmaceuticals.
AMGEN
AMGN
Mkt Cap251.94B
Amgen, a biotech firm, develops therapies that might directly compete with Claritas Pharmaceuticals' biopharmaceutical products.
Bristol-Myers Squibb
BMY
Mkt Cap127.71B
Bristol-Myers Squibb offers a range of prescription medicines that could directly compete with Claritas Pharmaceuticals.
Lilly(Eli) &
LLY
Mkt Cap1.26T
Eli Lilly and Company develops drugs that could be in direct competition with the treatments developed by Claritas Pharmaceuticals.
Sanofi
SNY
Mkt Cap106.24B
Sanofi produces a variety of pharmaceutical products that could compete across several of the same therapeutic areas as Claritas Pharmaceuticals.

About

Operating as a clinical-stage specialty pharmaceutical entity, Claritas Pharmaceuticals, Inc. is dedicated to the creation and market introduction of medical therapies addressing significant patient needs that are currently unfulfilled. Established in 2014, the company was previously known as Kalytera Therapeutics, Inc. before rebranding to Claritas Pharmaceuticals, Inc. in April 2021. Its corporate headquarters are located in San Rafael, California.
Show More
CEO
Robert Farrell
Employees
3
Country
Canada
ISIN
CA1806342061

Listings

STU
DE
S6V4.STU
OTC Link
US
CLAZF

0 Comments

Share your thoughts

FAQs

What is Claritas Pharmaceuticals stock price today?▼
The current price of CLAZF is $0.00 USD — it has increased by +0% in the past 24 hours. Watch Claritas Pharmaceuticals stock price performance more closely on the chart.
What is Claritas Pharmaceuticals stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on OTC Link exchange Claritas Pharmaceuticals stocks are traded under the ticker CLAZF.
Is Claritas Pharmaceuticals stock price growing?▼
CLAZF stock has risen by +0% compared to the previous week, the month change is a +0% rise, over the last year Claritas Pharmaceuticals has showed a +0% increase.
When is the next Claritas Pharmaceuticals earnings date?▼
Claritas Pharmaceuticals is going to release the next earnings report on November 30, 2026.
What is Claritas Pharmaceuticals revenue for the last year?▼
Claritas Pharmaceuticals revenue for the last year amounts to 0 USD.
What is Claritas Pharmaceuticals net income for the last year?▼
CLAZF net income for the last year is 4.21M USD.
How many employees does Claritas Pharmaceuticals have?▼
As of November 2, 2026, the company has 3 employees.
In which sector is Claritas Pharmaceuticals located?▼
Claritas Pharmaceuticals operates in the Health & Wellness sector.
When did Claritas Pharmaceuticals complete a stock split?▼
The last stock split for Claritas Pharmaceuticals was on July 23, 2021 with a ratio of 1:20.
Where is Claritas Pharmaceuticals headquartered?▼
Claritas Pharmaceuticals is headquartered in San Rafael, Canada.